Scientific Sessions 2025  /  Lipid Therapies: Translation to Implementation  /  Moving the Needle on Lipid Management: Getting to Goal
Logo

American Heart Association

  36
  0

Final ID:

Moving the Needle on Lipid Management: Getting to Goal

  • Schwartz, Gregory  ( VA EASTERN COLORADO HEALTHCARE SYST , Aurora , Colorado , United States )
    • Author Disclosures:
    Gregory Schwartz: DO have relevant financial relationships ; Researcher:AstraZeneca:Active (exists now) ; Researcher:Silence Therapeutics:Active (exists now) ; Researcher:Sanofi:Active (exists now)
Meeting Info:

Scientific Sessions 2025

2025

New Orleans, Louisiana

Session Info:

Lipid Therapies: Translation to Implementation

Monday, 11/10/2025 , 03:15PM - 04:30PM

Featured Science

More abstracts on this topic:
Dose-Dependent and Sustained Reduction in Lipoprotein(a) levels after single-dose of Kylo-11, a LPA-targeted Small Interfering RNA, in Healthy Volunteers: A First-in-Human Phase I Study

Du Xiaolin, Zhou Luping, Luo Jingying, Gu Yumei, Liu Ziyang, Zhang Qinsheng, Guan Tao, Cui Kunyuan, Yong Xiaolan

A Novel Approach to Manage Hypercholesterolemia: The Veterans Affairs Lipid Optimization Reimagined Quality Improvement (VALOR-QI) Program

Djousse Luc, Leesch Tharen, Pena David, Gaziano Michael, Ward Rachel, Wellman Helen, Yel Nedim, Santos Abigail, Delgrande Jen, Fink Abigail, Colson Kristin, Pan Eddie

More abstracts from these authors:
Discussant: META-AF

Potpara Tatjana, Chung Mina, Schwartz Gregory

The Effect of PCSK9 Inhibition With Alirocumab in Patients With Probable Familial Hypercholesterolemia or Type III Hyperlipoproteinemia: Results from the ODYSSEY OUTCOMES Trial

Geba Gregory, Bittner Vera, Bhatt Deepak, Szarek Michael, Schwartz Gregory, Steg Philippe, Fazio Sergio, Mohammadi Kusha, Damask Amy, Paulding Charles, Lotta Luca, Hindy George, Pordy Robert, Manvelian Garen, Shapiro Michael

You have to be authorized to contact abstract author. Please, Login
Not Available